Physician

Kishorkumar A Desai, M.D.

According to 2025 Medicare claims, Kishorkumar Desai, M.D. (NPI: 1124005038) practices rheumatology in the Clarksville, TN-KY market, with the plurality of this provider's patient population coming from Montgomery, TN. This provider's primary affiliated billing organization is WESTERN KY RHEUMATOLOGY, PLLC (NPI: 1285785816; TIN: 200797091) and primary practice location at 42240-1746.

Desai's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 752 traditional Medicare patients, billed 271,911 HCPCS/CPT codes, and received $1,531,335 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 4,323 prescription claims across 513 beneficiaries totaling $1,432,693 in drug costs, led by Enbrel Sureclick (Etanercept). 2016 DME data shows 11 claims. Open Payments data shows 26 records totaling $343,327. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $887,331 to $1,432,693. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	911	14,626	$389,089
2016	923	110,112	$958,590
2017	920	175,240	$1,407,447
2018	918	199,736	$1,726,633
2019	948	260,233	$2,163,717
2020	983	307,330	$2,537,870
2021	937	263,066	$2,074,961
2022	885	241,635	$1,675,114
2023	786	259,451	$1,580,843
2024	752	271,911	$1,531,335

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	603	6,086	$887,331
2016	616	6,235	$1,155,767
2017	590	5,821	$1,001,863
2018	593	4,854	$1,062,065
2019	579	4,743	$1,154,254
2020	597	4,893	$992,489
2021	569	4,704	$1,162,965
2022	576	4,654	$1,625,611
2023	518	4,141	$1,567,462
2024	513	4,323	$1,432,693

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	11	$210
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	208	337	$80
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	693	2,027	$58
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	479	888	$12
96372	Injection of drug or substance under skin or into muscle	134	1,406	$10
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	115	1,242	$1

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Enbrel Sureclick	Etanercept	58	1,764	$463,153
Humira(Cf) Pen	Adalimumab	49	1,596	$395,129
Benlysta	Belimumab	13	364	$63,277
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	757	40,008	$22,985
Methotrexate	Methotrexate Sodium	958	47,719	$18,950

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	10	$203	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	16	$343,124	E.R. Squibb & Sons, L.L.C.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Kishorkumar A. Desai, M.D.?

Tedicare shows public-source Medicare data for Kishorkumar A. Desai, M.D. (NPI 1124005038), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kishorkumar A. Desai, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Kishorkumar A. Desai, M.D.?

Kishorkumar A. Desai, M.D. is linked to WESTERN KY RHEUMATOLOGY, PLLC (billing NPI 1285785816) in the available physician profile data.

Does Kishorkumar A. Desai, M.D. have Open Payments data?

Kishorkumar A. Desai, M.D. has 26 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.